Funding For Neglected Diseases R&D Hits Record High In 2017, G-Finder Report Shows

BBC News: Global health research money reaches ‘record high’
“Funding to tackle 33 significant diseases has reached its highest level since figures were taken, says a survey which has tracked this for 11 years. The G-Finder report found that money invested in research and development reached $3.5bn (£2.8bn) in 2017. The total is a seven percent increase on the previous year…” (Dreaper, 1/23).

Nature: Neglected-disease research funding hits record high
“…Anna Doubell, director of research at Policy Cures Research, says that the launch of several trials testing new Ebola drugs, diagnostics, and vaccines in response to the Ebola crisis in West Africa between 2014 and 2016 might be giving donors hope that investments into neglected diseases pay off. ‘The amount of progress made in a short period of time after the Ebola outbreak might have brought in optimism about what is possible,’ Doubell says…” (Maxmen, 1/23).

Additional coverage of the G-Finder report is available from Business Day, The Telegraph, and The Wire.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.